Produção Nacional
Revisado por pares
Guidance on diagnosis, prevention and treatment of thromboembolic complications in COVID-19: a position paper of the Brazilian Society of Thrombosis and Hemostasis and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy
2020; Elsevier BV; Volume: 42; Issue: 4 Linguagem: Inglês
10.1016/j.htct.2020.06.001
ISSN2531-1387
AutoresFernanda Andrade Orsi, Erich Vinícius De Paula, Fernanda de Oliveira Santos, Marcelo Melzer Teruchkin, Dirceu Hamilton Cordeiro Campêlo, Tayana Teixeira Mello, Maria Chiara Chindamo, Ariane Vieira Scarlatelli Macedo, Ana Thereza Rocha, Eduardo Ramacciotti, Ana Clara Kneese Virgilio do Nascimento, Joyce Maria Annichino‐Bizzacchi, Dayse Maria Lourenço, João Carlos de Campos Guerra, Suely Meireles Rezende, Cyrillo Cavalheiro Filho,
Tópico(s)Dermatological and COVID-19 studies
ResumoHemostatic abnormalities and thrombotic risk associated with coronavirus disease 2019 (COVID-19) are among the most discussed topics in the management of this disease. The aim of this position paper is to provide the opinion of Brazilian experts on the thromboprophylaxis and management of thrombotic events in patients with suspected COVID-19, in the sphere of healthcare in Brazil. To do so, the Brazilian Society of Thrombosis and Hemostasis (BSTH) and the Thrombosis and Hemostasis Committee of the Brazilian Association of Hematology, Hemotherapy and Cellular Therapy (ABHH) have constituted a panel of experts to carefully review and discuss the available evidence about this topic. The data discussed in this document was reviewed by May 9, 2020. Recommendations and suggestions reflect the opinion of the panel and should be reviewed periodically as new evidence emerges.
Referência(s)